Quadrature Capital Ltd Cuts Stake in Doximity, Inc. (NASDAQ:DOCS)

Quadrature Capital Ltd lessened its holdings in Doximity, Inc. (NASDAQ:DOCS) by 61.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,755 shares of the company’s stock after selling 23,530 shares during the quarter. Quadrature Capital Ltd’s holdings in Doximity were worth $643,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in DOCS. Farther Finance Advisors LLC increased its holdings in shares of Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after buying an additional 603 shares during the period. Morse Asset Management Inc purchased a new position in Doximity in the 3rd quarter worth approximately $46,000. Blue Trust Inc. lifted its position in Doximity by 621.4% in the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock valued at $37,000 after purchasing an additional 1,193 shares during the last quarter. GAMMA Investing LLC lifted its position in Doximity by 40.1% in the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock valued at $63,000 after purchasing an additional 412 shares during the last quarter. Finally, Quarry LP boosted its stake in shares of Doximity by 101.2% during the second quarter. Quarry LP now owns 1,616 shares of the company’s stock valued at $45,000 after purchasing an additional 131,253 shares during the period. 87.19% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently commented on DOCS. Barclays lifted their target price on shares of Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a research note on Monday, November 11th. Baird R W upgraded shares of Doximity to a “strong-buy” rating in a research report on Tuesday, September 17th. KeyCorp upgraded shares of Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 target price for the company in a report on Friday, November 8th. Morgan Stanley upgraded Doximity from an “underweight” rating to an “equal weight” rating and boosted their price target for the company from $33.00 to $53.00 in a report on Thursday, November 14th. Finally, Raymond James reaffirmed an “outperform” rating and set a $65.00 price target (up previously from $37.00) on shares of Doximity in a research report on Friday, November 8th. Twelve analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Doximity presently has an average rating of “Hold” and an average target price of $52.44.

Doximity Trading Up 0.4 %

Shares of Doximity stock opened at $55.53 on Monday. The business has a fifty day simple moving average of $47.11 and a two-hundred day simple moving average of $37.07. The firm has a market capitalization of $10.37 billion, a P/E ratio of 63.83, a P/E/G ratio of 4.34 and a beta of 1.40. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $61.75.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.